The Microbial Metabolites, Short-Chain Fatty Acids, Regulate Colonic T reg Cell Homeostasis
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Regulatory T cells (Tregs) that express the transcription factor Foxp3 are critical for regulating intestinal inflammation. Candidate microbe approaches have identified bacterial species and strain-specific molecules that can affect intestinal immune responses, including species that modulate Treg responses. Because neither all humans nor mice harbor the same bacterial strains, we posited that more prevalent factors exist that regulate the number and function of colonic Tregs. We determined that short-chain fatty acids, gut microbiota-derived bacterial fermentation products, regulate the size and function of the colonic Treg pool and protect against colitis in a Ffar2-dependent manner in mice. Our study reveals that a class of abundant microbial metabolites underlies adaptive immune microbiota coadaptation and promotes colonic homeostasis and health.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“acetate and propionate, but not butyrate, stimulate the expansion of pre-existing colonic Tregs (cTregs)”
From Understanding the Holobiont: How Microbial Metabolites Affect Human Health and Shape the Immune System (2017) · cites this paper as Smith et al., 2013
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source doesn’t support the claim as written.
In the citing paper
“and on DCs, conferring a higher capacity to drive naïve T cell differentiation into Tregs [38-40].”
From Antibiotic-Induced Changes in the Intestinal Microbiota and Disease (2016) · cites this paper as [40]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source doesn’t support the claim as written.
In the citing paper
“SCFAs promote the development of naive CD4+ T cells into regulatory T cells (31, 32), induce “tolerogenic” dendritic cells in the intestinal mucosa (33), and limit autoimmity (34, 35).”
From Respiratory viral infection-induced microbiome alterations and secondary bacterial pneumonia. (2018) · cites this paper as [31]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“SCFAs serve as ligands for GPR41 and GPR43 on intestinal Tregs and epithelial cells, leading to activation mitogen-activated protein kinase signaling and secretion of chemokines and cytokines11,40.”
From Microbial short-chain fatty acids modulate CD8+ T cell responses and improve adoptive immunotherapy for cancer (2021) · cites this paper as [11]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“SCFAs have context-dependent functions: they can promote the expansion of Treg cells and also improve effector T cell functions133–136.”
From Gut OncoMicrobiome Signatures (GOMS) as next-generation biomarkers for cancer immunotherapy (2023) · cites this paper as [134]
Experimental — accuracy not yet measured
22 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Structure, function and diversity of the healthy human microbiome
The Human Microbiome Project Consortium (2012) · Nature · doi:10.1038/nature11234 · Cited by 11,726
A human gut microbial gene catalogue established by metagenomic sequencing
MetaHIT Consortium, Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K. S., Manichanh, C., Nielsen, T., Pons, N., Levenez, F., et al. (2010) · Nature · doi:10.1038/nature08821 · Cited by 11,624 · cited 1×
“While the gut microbiota composition is divergent across individuals, functional gene profiles are quite similar (24, 25), and alterations to common gut microbial metabolic pathways may affect production of symbiotic factors, such as SCFA, which regulate intestinal adaptive immune responses and promote health.”
BackgroundDe Filippo, C., Cavalieri, D., Di Paola, M., Ramazzotti, M., Poullet, J. B., Massart, S., Collini, S., Pieraccini, G., & Lionetti, P. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1005963107 · Cited by 5,579 · cited 1×
“The western dietary pattern, specifically reduced ingestion of plant-based fibers, may be a critical factor that links the gut microbiome to disease (23).”
BackgroundDiversity, stability and resilience of the human gut microbiota
Lozupone, C. A., Stombaugh, J. I., Gordon, J. I., Jansson, J. K., & Knight, R. (2012) · Nature · doi:10.1038/nature11550 · Cited by 5,533 · cited 1×
“Gut microbiota-host immune misadaptation has been implicated in the rising incidence of IBD, other inflammatory diseases, and obesity (22).”
BackgroundInteractions Between the Microbiota and the Immune System
Hooper, L. V., Littman, D. R., & Macpherson, A. J. (2012) · Science · doi:10.1126/science.1223490 · Cited by 4,173 · cited 1×
“Disruption of this homeostasis leads to intestinal inflammation and disease (2, 3).”
BackgroundInduction of Colonic Regulatory T Cells by Indigenous Clostridium Species
Atarashi, K., Tanoue, T., Shima, T., Imaoka, A., Kuwahara, T., Momose, Y., Cheng, G., Yamasaki, S., Saito, T., Ohba, Y., et al. (2011) · Science · doi:10.1126/science.1198469 · Cited by 3,752 · cited 4×
“The antibiotic vancomycin, which targets Gram-positive bacteria and disrupts the gut microbiota (12), reduces cTregs to similar levels as observed in GF mice (7) (fig.”
BackgroundInfluentialEcological and Evolutionary Forces Shaping Microbial Diversity in the Human Intestine
Ley, R. E., Peterson, D. A., & Gordon, J. I. (2006) · Cell · doi:10.1016/j.cell.2006.02.017 · Cited by 3,358 · cited 1×
“Humans and mice rely on bacteria to breakdown undigestible dietary components, such as fibers (8).”
BackgroundRegulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43
Maslowski, K. M., Vieira, A. T., Ng, A., Kranich, J., Sierro, F., Yu, D., Schilter, H. C., Rolph, M. S., Mackay, F., Artis, D., et al. (2009) · Nature · doi:10.1038/nature08530 · Cited by 3,241
Short chain fatty acids in human large intestine, portal, hepatic and venous blood
Cummings, J. H., Pomare, E. W., Branch, W. J., Naylor, C. P., & Macfarlane, G. T. (1987) · Gut · doi:10.1136/gut.28.10.1221 · Cited by 3,119 · cited 2×
“In SPF mice, SCFA are taken up by colonic epithelial cells but also diffuse through the epithelium into the lamina propria where they can mediate their effects directly (9, 14).”
BackgroundBifidobacteria can protect from enteropathogenic infection through production of acetate
Fukuda, S., Toh, H., Hase, K., Oshima, K., Nakanishi, Y., Yoshimura, K., Tobe, T., Clarke, J. M., Topping, D. L., Suzuki, T., et al. (2011) · Nature · doi:10.1038/nature09646 · Cited by 2,387 · cited 1×
“These results may explain the benefits of dietary fibers and bacteria, such as clostridia and bifidobacteria (13) that can increase colonic luminal SCFA production and modulate inflammation in mice and humans.”
Background
Cited by
Items 701–800 of 1,070
Vieira, A. T., Galvão, I., Macia, L. M., Sernaglia, É. M., Vinolo, M. A. R., Garcia, C. C., Tavares, L. P., Amaral, F. A., Sousa, L. P., Martins, F. S., et al. (2017) · Journal of Leukocyte Biology · doi:10.1189/jlb.3a1015-453rrr · Cited by 163
“It has been shown that SCFAs mediate profound anti-inflammatory effects in chronic diseases [12, 13].”
BackgroundThe gut microbiota in mouse models of inflammatory bowel disease
Gkouskou, K. K., Deligianni, C., Tsatsanis, C., & Eliopoulos, A. G. (2014) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2014.00028 · Cited by 162
Dual role of microbiota-derived short-chain fatty acids on host and pathogen
Mirzaei, R., Dehkhodaie, E., Bouzari, B., Rahimi, M., Gholestani, A., Hosseini-Fard, S. R., Keyvani, H., Teimoori, A., & Karampoor, S. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112352 · Cited by 163
Shahini, A., & Shahini, A. (2022) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-022-00695-x · Cited by 186
The role of short-chain fatty acids in inflammatory skin diseases
Xiao, X., Hu, X., Yao, J., Cao, W., Zou, Z., Wang, L., Qin, H., Zhong, D., Li, Y., Xue, P., et al. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1083432 · Cited by 160
Liu, Q., Tian, X., Maruyama, D., Arjomandi, M., & Prakash, A. (2021) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00421.2020 · Cited by 161
Brennan, C. A., Clay, S. L., Lavoie, S. L., Bae, S., Lang, J. K., Fonseca-Pereira, D., Rosinski, K. G., Ou, N., Glickman, J. N., & Garrett, W. S. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1987780 · Cited by 161
Self-citationKandpal, M., Indari, O., Baral, B., Jakhmola, S., Tiwari, D., Bhandari, V., Pandey, R. K., Bala, K., Sonawane, A., & Jha, H. C. (2022) · Metabolites · doi:10.3390/metabo12111064 · Cited by 159
Gut Microbiota in Colorectal Cancer: Biological Role and Therapeutic Opportunities
Pandey, H., Tang, D. W. T., Wong, S. H., & Lal, D. (2023) · Cancers · doi:10.3390/cancers15030866 · Cited by 159
Gut microbiota derived bile acid metabolites maintain the homeostasis of gut and systemic immunity
Su, X., Gao, Y., & Yang, R. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1127743 · Cited by 159
Advantages and Limitations of the Neonatal Immune System
Tsafaras, G. P., Ntontsi, P., & Xanthou, G. (2020) · Frontiers in Pediatrics · doi:10.3389/fped.2020.00005 · Cited by 161
“Moreover, recent studies have shown that the metabolome is significantly altered in germ-free mice (56), while the administration of probiotics and prebiotics affect metabolite composition (57, 58).”
BackgroundGut Microbiota Dysbiosis and Increased Plasma LPS and TMAO Levels in Patients With Preeclampsia
Wang, J., Gu, X., Yang, J., Wei, Y., & Zhao, Y. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00409 · Cited by 161
Targeting the gut-liver-immune axis to treat cirrhosis
Tranah, T. H., Edwards, L. A., Schnabl, B., & Shawcross, D. L. (2021) · Gut · doi:10.1136/gutjnl-2020-320786 · Cited by 161
Zhang, Y. L., Ji, W., Qin, H., Chen, Z., Zhou, Y., Zhou, Z., Wang, J., & Wang, K. (2024) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2024.122829 · Cited by 207
Bacteroidetes Species Are Correlated with Disease Activity in Ulcerative Colitis
Nomura, K., Ishikawa, D., Okahara, K., Ito, S., Haga, K., Takahashi, M., Arakawa, A., Shibuya, T., Osada, T., Kuwahara-Arai, K., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10081749 · Cited by 150
“The genus Bacteroides, belonging to the phylum Bacteroidetes, produces short chain fatty acids, which increase the number of colonic Treg cells by encouraging the migration of extraintestinal Treg cells [43,44].”
BackgroundWhen pathogenic bacteria meet the intestinal microbiota
Rolhion, N., & Chassaing, B. (2016) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2015.0504 · Cited by 160
Regulatory T cell adaptation in the intestine and skin
Whibley, N., Tucci, A., & Powrie, F. (2019) · Nature Immunology · doi:10.1038/s41590-019-0351-z · Cited by 160
Visekruna, A., & Luu, M. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.703218 · Cited by 174
Diet and microbiota in inflammatory bowel disease: The gut in disharmony
Rapozo, D. C. M., Bernardazzi, C., & de Souza, H. S. P. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i12.2124 · Cited by 158
Mafra, D., Lobo, J. C., Barros, A. F., Koppe, L., Vaziri, N. D., & Fouque, D. (2014) · Future Microbiology · doi:10.2217/fmb.13.165 · Cited by 157
The Microbiome, Timing, and Barrier Function in the Context of Allergic Disease
Wesemann, D. R., & Nagler, C. R. (2016) · Immunity · doi:10.1016/j.immuni.2016.02.002 · Cited by 158
“Several reports have shown that bacteria-produced short chain fatty acids (SCFAs) regulate both the proportions and functional capabilities of intestinal Treg cells (Arpaia et al., 2013; Furusawa et al., 2013; Smith et al., 2013).”
Nastasi, C., Fredholm, S., Willerslev-Olsen, A., Hansen, M., Bonefeld, C. M., Geisler, C., Andersen, M. H., Ødum, N., & Woetmann, A. (2017) · Scientific Reports · doi:10.1038/s41598-017-15099-w · Cited by 157
Kim, Y., Keogh, J. B., & Clifton, P. M. (2017) · Nutrients · doi:10.3390/nu9111271 · Cited by 174
Guinan, J., Wang, S., Hazbun, T. R., Yadav, H., & Thangamani, S. (2019) · Scientific Reports · doi:10.1038/s41598-019-45467-7 · Cited by 156
Bioactive Factors in Human Breast Milk Attenuate Intestinal Inflammation during Early Life
Thai, J. D., & Gregory, K. E. (2020) · Nutrients · doi:10.3390/nu12020581 · Cited by 177
Bultman, S. J. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-2483 · Cited by 157
Long term effect of gut microbiota transfer on diabetes development
Peng, J., Narasimhan, S., Marchesi, J. R., Benson, A., Wong, F. S., & Wen, L. (2014) · Journal of Autoimmunity · doi:10.1016/j.jaut.2014.03.005 · Cited by 158
The Environment of Regulatory T Cell Biology: Cytokines, Metabolites, and the Microbiome
Hoeppli, R. E., Wu, D., Cook, L., & Levings, M. K. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00061 · Cited by 177
Nakamura, Y., Janowitz, C., Metea, C., Asquith, M. J., Karstens, L., Rosenbaum, J. T., & Lin, P. (2017) · Scientific Reports · doi:10.1038/s41598-017-12163-3 · Cited by 170
Zeng, Q., Gong, J., Liu, X., Chen, C., Sun, X., Li, H., Zhou, Y., Cui, C., Wang, Y., Yang, Y., et al. (2019) · Neurochemistry International · doi:10.1016/j.neuint.2019.104468 · Cited by 164
Microenvironmental Metabolism Regulates Antitumor Immunity
Ngwa, V. M., Edwards, D. N., Philip, M., & Chen, J. (2019) · Cancer Research · doi:10.1158/0008-5472.can-19-0617 · Cited by 171
Short-chain fatty acids affect cystic fibrosis airway inflammation and bacterial growth
Ghorbani, P., Santhakumar, P., Hu, Q., Djiadeu, P., Wolever, T. M. S., Palaniyar, N., & Grasemann, H. (2015) · European Respiratory Journal · doi:10.1183/09031936.00143614 · Cited by 156
Gut Microbiota in Anxiety and Depression: Unveiling the Relationships and Management Options
Kumar, A., Pramanik, J., Goyal, N., Chauhan, D., Sivamaruthi, B. S., Prajapati, B. G., & Chaiyasut, C. (2023) · Pharmaceuticals · doi:10.3390/ph16040565 · Cited by 154
Gut microbiota shapes cancer immunotherapy responses
Lei, W., Zhou, K., Lei, Y., Li, Q., & Zhu, H. (2025) · npj Biofilms and Microbiomes · doi:10.1038/s41522-025-00786-8 · Cited by 195
The impact of a helminth-modified microbiome on host immunity
Brosschot, T. P., & Reynolds, L. A. (2018) · Mucosal Immunology · doi:10.1038/s41385-018-0008-5 · Cited by 182
Disease Tolerance as an Inherent Component of Immunity
Martins, R., Carlos, A. R., Braza, F., Thompson, J. A., Bastos-Amador, P., Ramos, S., & Soares, M. P. (2019) · Annual Review of Immunology · doi:10.1146/annurev-immunol-042718-041739 · Cited by 164
Zou, F., Qiu, Y., Huang, Y., Zou, H., Xiao, C., Niu, Q., Luo, A., & Sun, J. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03880-9 · Cited by 170
The Detrimental Impact of Ultra-Processed Foods on the Human Gut Microbiome and Gut Barrier
Rondinella, D., Raoul, P. C., Valeriani, E., Venturini, I., Cintoni, M., Severino, A., Galli, F. S., Mora, V., Mele, M. C., Cammarota, G., et al. (2025) · Nutrients · doi:10.3390/nu17050859 · Cited by 213
“Notably, in IBD patients, three main pathways are affected: SCFA production [106], bile acid metabolism [53], and tryptophan metabolism [54].”
Blastocystis: getting to grips with our guileful guest
Scanlan, P. D., & Stensvold, C. R. (2013) · Trends in Parasitology · doi:10.1016/j.pt.2013.08.006 · Cited by 179
Jiang, S., Xie, S., Lv, D., Zhang, Y., Deng, J., Zeng, L., & Chen, Y. (2016) · Antonie van Leeuwenhoek · doi:10.1007/s10482-016-0737-y · Cited by 169
Roles of Regulatory T Cells in Tissue Pathophysiology and Metabolism
Campbell, C., & Rudensky, A. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2019.09.010 · Cited by 154
Impact of Microbial Metabolites on Microbiota–Gut–Brain Axis in Inflammatory Bowel Disease
Banfi, D., Moro, E., Bosi, A., Bistoletti, M., Cerantola, S., Crema, F., Maggi, F., Giron, M. C., Giaroni, C., & Baj, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041623 · Cited by 174
Targeting the gut microbiota and its metabolites for type 2 diabetes mellitus
Wu, J., Yang, K., Fan, H., Wei, M., & Xiong, Q. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1114424 · Cited by 203
Uchimura, Y., Fuhrer, T., Li, H., Lawson, M. A., Zimmermann, M., Yilmaz, B., Zindel, J., Ronchi, F., Sorribas, M., Hapfelmeier, S., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.08.004 · Cited by 153
“A Broad Scope of Intestinal Bacterial-Derived Metabolites Penetrates Host Systemic Organs While a few microbial metabolites, such as short chain fatty acids or aryl hydrocarbon receptor ligands, are well known to shape host metabolism and immune functions (Arpaia et al., 2013; Gomez de Ag€ uero et al., 2016; Perry et…”
BackgroundHost–microbe interactions shaping the gastrointestinal environment
Kaiko, G. E., & Stappenbeck, T. S. (2014) · Trends in Immunology · doi:10.1016/j.it.2014.08.002 · Cited by 180
Vijay-Kumar, M., Chassaing, B., Kumar, M., Baker, M., & Singh, V. (2014) · Biomedical Journal · doi:10.4103/2319-4170.130922 · Cited by 153
Schilderink, R., Verseijden, C., Seppen, J., Muncan, V., van den Brink, G. R., Lambers, T. T., van Tol, E. A., & de Jonge, W. J. (2016) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00411.2015 · Cited by 153
Chi, L., Bian, X., Gao, B., Tu, P., Ru, H., & Lü, K. (2017) · Toxicological Sciences · doi:10.1093/toxsci/kfx174 · Cited by 164
Sex and strain dependent differences in mucosal immunology and microbiota composition in mice
Elderman, M., Hugenholtz, F., Belzer, C., Boekschoten, M., van Beek, A., de Haan, B., Savelkoul, H., de Vos, P., & Faas, M. (2018) · Biology of Sex Differences · doi:10.1186/s13293-018-0186-6 · Cited by 151
Role of diet and gut microbiota on colorectal cancer immunomodulation
Almeida, C. V. D., Camargo, M. R. D., Russo, E., & Amedei, A. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i2.151 · Cited by 151
Short-chain fatty acids-producing probiotics: A novel source of psychobiotics
Cheng, Y., Liu, J., & Ling, Z. (2021) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.1920884 · Cited by 169
Shen, Q., Huang, Z., Yao, J., & Jin, Y. (2021) · Journal of Advanced Research · doi:10.1016/j.jare.2021.07.002 · Cited by 172
Towards modulating the gut microbiota to enhance the efficacy of immune-checkpoint inhibitors
Simpson, R. C., Shanahan, E. R., Scolyer, R. A., & Long, G. V. (2023) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-023-00803-9 · Cited by 153
Microbial view of central nervous system autoimmunity
Berer, K., & Krishnamoorthy, G. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.04.007 · Cited by 152
Kanda, N., Hoashi, T., & Saeki, H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155405 · Cited by 189
Deconstructing Mechanisms of Diet-Microbiome-Immune Interactions
Alexander, M., & Turnbaugh, P. J. (2020) · Immunity · doi:10.1016/j.immuni.2020.07.015 · Cited by 150
Implications of Gut Microbiota in Neurodegenerative Diseases
Zhang, H., Chen, Y., Wang, Z., Xie, G., Liu, M., Yuan, B., Chai, H., Wang, W., & Cheng, P. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.785644 · Cited by 177
Nutritional regulation of microbiota-derived metabolites: Implications for immunity and inflammation
Arifuzzaman, M., Collins, N., Guo, C., & Artis, D. (2024) · Immunity · doi:10.1016/j.immuni.2023.12.009 · Cited by 169
O'Sullivan, A., Farver, M., & Smilowitz, J. T. (2015) · Nutrition and Metabolic Insights · doi:10.4137/nmi.s29530 · Cited by 143
Hu, M., Eviston, D., Hsu, P., Mariño, E., Chidgey, A., Santner-Nanan, B., Wong, K., Richards, J. L., Yap, Y. A., Collier, F., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10703-1 · Cited by 151
He, K.-Y., Lei, X., Wu, D., Zhang, L., Li, J.-Q., Li, Q., Yin, W.-T., Zhao, Z., Liu, H., Xiang, X.-Y., et al. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2293312 · Cited by 176
Helicobacter species are potent drivers of colonic T cell responses in homeostasis and inflammation
Chai, J. N., Peng, Y., Rengarajan, S., Solomon, B. D., Ai, T. L., Shen, Z., Perry, J. S. A., Knoop, K. A., Tanoue, T., Narushima, S., et al. (2017) · Science Immunology · doi:10.1126/sciimmunol.aal5068 · Cited by 149
Perinatal Interactions between the Microbiome, Immunity, and Neurodevelopment
Pronovost, G. N., & Hsiao, E. Y. (2019) · Immunity · doi:10.1016/j.immuni.2018.11.016 · Cited by 149
Toward Understanding Microbiome-Neuronal Signaling
Jameson, K. G., Olson, C. A., Kazmi, S. A., & Hsiao, E. Y. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.03.006 · Cited by 149
Emerging concepts in intestinal immune control of obesity-related metabolic disease
Khan, S., Luck, H., Winer, S., & Winer, D. A. (2021) · Nature Communications · doi:10.1038/s41467-021-22727-7 · Cited by 149
Pan, R., Wang, L., Xu, X., Chen, Y., Wang, H., Wang, G., Zhao, J., & Chen, W. (2022) · Nutrients · doi:10.3390/nu14183704 · Cited by 149
Fung, T. C., Bessman, N. J., Hepworth, M. R., Kumar, N., Shibata, N., Kobuley, D., Wang, K., Ziegler, C. G. K., Goc, J., Shima, T., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.02.019 · Cited by 148
Dutta, S. K., Verma, S., Jain, V., Surapaneni, B. K., Vinayek, R., Phillips, L., & Nair, P. P. (2019) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm19044 · Cited by 149
Chen, Y., Fang, L., Chen, S., Zhou, H., Fan, Y., Lin, L., Li, J., Xu, J., Chen, Y., Ma, Y., et al. (2020) · BioMed Research International · doi:10.1155/2020/8456596 · Cited by 146
Integrated microbiota and metabolite profiles link Crohn’s disease to sulfur metabolism
Metwaly, A., Dunkel, A., Waldschmitt, N., Raj, A. C. D., Lagkouvardos, I., Corraliza, A. M., Mayorgas, A., Martinez-Medina, M., Reiter, S., Schloter, M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17956-1 · Cited by 149
Yan, X., Liu, X.-Y., Zhang, D., Zhang, Y., Li, Z., Liu, X., Wu, F., & Chen, G. (2021) · Cellular and Molecular Immunology · doi:10.1038/s41423-021-00760-2 · Cited by 162
Microbiota, Inflammation and Obesity
Sanz, Y., & Moya-Pérez, Á. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-1-4939-0897-4_14 · Cited by 166
Hedin, C. R., McCarthy, N. E., Louis, P., Farquharson, F. M., McCartney, S., Taylor, K., Prescott, N. J., Murrells, T., Stagg, A. J., Whelan, K., et al. (2014) · Gut · doi:10.1136/gutjnl-2013-306226 · Cited by 148
Environmental factors in autoimmune diseases and their role in multiple sclerosis
Haase, S., Grohme, D. A., Erzler, M., Binsfeld, M., Haghikia, A., Müller, D. N., Linker, R. A., & Kleinewietfeld, M. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2311-1 · Cited by 168
Microbiota-derived butyrate regulates intestinal inflammation: Focus on inflammatory bowel disease
Couto, M. R., Gonçalves, P., Magro, F., & Martel, F. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104947 · Cited by 167
The gut microbiota and the metabolic health of the host
Joyce, S. A., & Gahan, C. G. M. (2014) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000039 · Cited by 147
T-Cell-Driven Inflammation as a Mediator of the Gut-Brain Axis Involved in Parkinson's Disease
Campos-Acuña, J., Elgueta, D., & Pacheco, R. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00239 · Cited by 147
The correlation between the Th17/Treg cell balance and bone health
Zhu, L., Hua, F., Ding, W., Ding, K., Zhang, Y., & Xu, C. (2020) · Immunity & Ageing · doi:10.1186/s12979-020-00202-z · Cited by 146
Rapid and Efficient Generation of Regulatory T Cells to Commensal Antigens in the Periphery
Nutsch, K., Chai, J. N., Ai, T. L., Russler-Germain, E., Feehley, T., Nagler, C. R., & Hsieh, C.-S. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.08.092 · Cited by 145
Histone deacetylase function in CD4+ T cells
Ellmeier, W., & Seiser, C. (2018) · Nature reviews. Immunology · doi:10.1038/s41577-018-0037-z · Cited by 157
Cait, A., Cardenas, E., Dimitriu, P. A., Amenyogbe, N., Dai, D. L., Cait, J., Sbihi, H., Stiemsma, L. T., Subbarao, P., Mandhane, P. J., et al. (2019) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2019.06.029 · Cited by 163
Gut hormones in microbiota-gut-brain cross-talk
Sun, L.-J., Li, J.-N., & Nie, Y.-Z. (2020) · Chinese Medical Journal · doi:10.1097/cm9.0000000000000706 · Cited by 145
“It has been reported that SCFAs could play roles in glucose homeostasis, reduction of food intake, and modulation of lymphocyte function([13,14]) either through G-protein-coupled receptors (GPCRs) or acting as epigenetic modulators of histone deacetylases.”
BackgroundDiet, gut microbiota and cognition
Proctor, C., Thiennimitr, P., Chattipakorn, N., & Chattipakorn, S. C. (2017) · Metabolic Brain Disease · doi:10.1007/s11011-016-9917-8 · Cited by 144
The homeostatic role of neuropeptide Yin immune function and its impact on mood and behaviour
Farzi, A., Reichmann, F., & Holzer, P. (2015) · Acta Physiologica · doi:10.1111/apha.12445 · Cited by 145
“Published by John Wiley & Sons Ltd, doi: 10.1111/apha.12445 611 actions on the function of the colonic mucosa and immune system (Hamer et al. 2008, Tazoe et al. 2008, Guilloteau et al. 2010, Macia et al. 2012a, Smith et al. 2013).”
BackgroundInfluentialA potential role for the gut microbiome in substance use disorders
Meckel, K. R., & Kiraly, D. D. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05232-0 · Cited by 145
He, M. R., Li, X., Poolsawat, L., Guo, Z., Yao, W., Zhang, C., & Leng, X. (2020) · Aquaculture Nutrition · doi:10.1111/anu.13064 · Cited by 157
Gut dysbiosis: Ecological causes and causative effects on human disease
Winter, S., & Bäumler, A. J. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2316579120 · Cited by 181
Does consumption of fermented foods modify the human gut microbiota?
Stiemsma, L. T., Nakamura, R. E., Nguyen, J. G., & Michels, K. B. (2020) · The Journal of Nutrition · doi:10.1093/jn/nxaa077 · Cited by 144
“These particular metabolites also modulate gut immune function and energy production by colonic cells, affecting host–microbiota interactions (28, 30).”
BackgroundZhuang, X., Li, T., Li, M., Huang, S., Qiu, Y., Feng, R., Zhang, S., Chen, M., Xiong, L., & Zeng, Z. (2019) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izz188 · Cited by 152
The Evolving Microbiome from Pregnancy to Early Infancy: A Comprehensive Review
Mesa, M. D., Loureiro, B., Iglesia, I., Fernandez Gonzalez, S., Llurba Olivé, E., García Algar, O., Solana, M. J., Cabero Perez, M. J., Sainz, T., Martinez, L., et al. (2020) · Nutrients · doi:10.3390/nu12010133 · Cited by 143
Barrio, C., Arias-Sánchez, S., & Martín-Monzón, I. (2022) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2021.105640 · Cited by 143
Induction of regulatory T cells: A role for probiotics and prebiotics to suppress autoimmunity
Dwivedi, M., Kumar, P., Laddha, N. C., & Kemp, E. H. (2016) · Autoimmunity Reviews · doi:10.1016/j.autrev.2016.01.002 · Cited by 158
The gut microbiota and inflammatory bowel diseases
Miyoshi, J., & Chang, E. B. (2017) · Translational Research · doi:10.1016/j.trsl.2016.06.002 · Cited by 144
Wang, S., Lv, D., Jiang, S., Jiang, J., Liang, M., Hou, F. F., & Chen, Y. (2019) · Clinical Science · doi:10.1042/cs20190171 · Cited by 158
Impact of prebiotics on immune response: from the bench to the clinic
Pujari, R., & Banerjee, G. (2021) · Immunology & Cell Biology · doi:10.1111/imcb.12409 · Cited by 143
Short-chain fatty acids in cancer pathogenesis
Feitelson, M. A., Arzumanyan, A. L., Medhat, A., & Spector, I. (2023) · Cancer and Metastasis Reviews · doi:10.1007/s10555-023-10117-y · Cited by 162
Non-Invasive Drug Delivery across the Blood–Brain Barrier: A Prospective Analysis
Niazi, S. K. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15112599 · Cited by 170
Probiotics as Complementary Treatment for Metabolic Disorders
Le Barz, M., Anhê, F. F., Varin, T. V., Desjardins, Y., Levy, E., Roy, D., Urdaci, M. C., & Marette, A. (2015) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2015.39.4.291 · Cited by 142
“Inoculation of mice with the butyrate-producers Clostridium cluster IV and XIVa or butyrate administration per se were both capable of expanding the colonic population of regulatory T cells (Treg), which increases the production of the anti-inflammatory cytokine interleukin 10 and reduces the colonic population of the…”
BackgroundThe intestinal microbiome in spondyloarthritis
Gill, T., Asquith, M. J., Rosenbaum, J. T., & Colbert, R. A. (2015) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000187 · Cited by 165
Daïen, C. I., Pinget, G. V., Tan, J. K., & Macia, L. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00548 · Cited by 142
Metadata
- Authors
- Smith, P. M., Howitt, M. R., Panikov, N., Michaud, M., Gallini, C. A., Bohlooly-Y, M., Glickman, J. N., & Garrett, W. S.
- Affiliations
- Harvard University (US)
- AstraZeneca, RAD-Transgenic, Mölndal, Sweden.
- Broad Institute (US)
- Corresponding author
- Garrett, Wendy S.
- Venue
- Science
- Published
- 2013-08-02
- Volume
- 341
- Issue
- 6145
- Pages
- 569-573
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC3807819
- OpenAlex
- W2060185417
- Cited by
- 5,413
- References
- 28
- Citations by year
- 2026: 483 · 2025: 507 · 2024: 556 · 2023: 551 · 2022: 497 · 2021: 560 · 2020: 452 · 2019: 403 · 2018: 344 · 2017: 319 · 2016: 276 · 2015: 226 · 2014: 204 · 2013: 31
- FWCI
- 109.95
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- Funders
- National Cancer Institute (R01CA154426)
- National Institute of General Medical Sciences (R01GM099537)
- National Institute of Allergy and Infectious Diseases (K08AI078942)
- National Institute of Diabetes and Digestive and Kidney Diseases (F32DK098826, F32DK095506, P30DK034854)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Keywords
- regulatory T cells, Foxp3, short-chain fatty acids, gut microbiota, microbial metabolites, colitis, FFAR2, intestinal inflammation, bacterial fermentation products
- MeSH terms
- Animals, Bacteria, Colitis, Colon, DNA-Binding Proteins, Fatty Acids, Volatile, Fermentation, Germ-Free Life, Homeostasis, Humans, Mice, Inbred BALB C, Mice, Inbred C57BL, Receptors, G-Protein-Coupled, T-Lymphocytes, Regulatory, Mice, Metagenome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.